And before anybody tries to counter by stating that this new trial for NSAID/Nurofen is a human clinical trial (in vivo), OBJ did conduct a few human clinical trials for various molecules over the years, including this one for Tetracaine (local anaesthetic) via Dermaportation again (with 5 subjects):
http://www.asx.com.au/asxpdf/20060419/pdf/3wc70bhcfcn25.pdf
http://www.asx.com.au/asxpdf/20061207/pdf/31008146gp2s5q.pdf
I'm really beginning to question and wonder exactly how good Dermaportation is, especially given the fact that COTY are taking their sweet, sweet, sweet time to seal a deal.
Jeff Edwards was given a substantial portion of shares in OBJ in 2004 when OBJ was re-born and it was all pretty much at the time for Dermaportation, via International Scientific Pty Ltd:
http://www.asx.com.au/asxpdf/20040824/pdf/3mkwbrbxwybns.pdf
I'm not 100% sure whether they went on to claim the A & B Class Shares back then for a 5 person trial or whether they met them in relation to one of the other larger trials (certainly not C Class). Need somebody not too time poor to scrutinise all the announcements.
So to me, it looks like after all the various Dermaportation trials (there have been a few), not one has led to a single cent for Shareholders...yet. Dermaportation is OBJ's foundation tech platform to which OBJ was born.
Although Directors have participated very mildly imo in some of the Capital Raises over the years and I tried to politely have this discussion with Abdm, where he decided not to reply as to the exact average price these guys have paid over the years across all the freebies, performance shares etc; I guess it's just too hard to work out among the plethora of announcements back then. Although I definately have strong suspicions already it is a very, very low low average.
My biggest concern here is that Dermaportation since inception is yet to monetised after 13 years ie the foundation on which this company was created is yet to earn a cent....
Alot of other progress has occurred outside of Dermaportation, so I really do hope that this new Pharmaceutical trial for Nurofen is NOT utilsing The Dermaportation platform in any fashion whatsoever.
- Forums
- ASX - By Stock
- WFL
- Ann: Clinical Trial for BodyGuard Technology
Ann: Clinical Trial for BodyGuard Technology, page-58
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable